http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-050786-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-050786-A1
titleOfInvention COMPOUNDS AND USEFUL COMPOSITIONS AS INHIBITORS OF CATEPSINA-S
abstract This refers to the use of a 2-cyano-pyrimidine compound of the formula (1), wherein: R1, R2, R3 and X are as defined in the specification and in the claims, in free form or in salt form, and where possible, in tautomeric form, as an inhibitor of the activity of cathepsin S. Claim 1: A 2-cyano-pyrimidine of the formula (1), R1 denotes a radical of the formula (2) , wherein A, E, and G, independently of each other, represent O, S, or CH2, with the proviso that at least one of A and E represents CH2; T is O, S, or a link, if G is CH2, and T is a link if G is O or S; Ra, Rb, and Rc, independently of each other, represent hydrogen or C1-4 alkyl; s is 0, 1 or 2, t is 1, 2, 3, or 4, and p is 0, 1, or 2; R2 denotes halogen, C1-4 alkyl, unsubstituted or substituted aryl, 5- or 6-membered heterocyclyl -C (O) NR4R5, -NHC (O) R4, or CH2NHC (O) R4, wherein: R4 represents: a) alkyl C1-7 which is unsubstituted or substituted by halogen; amino, which is mono- or di-substituted by C3-5 cycloalkyl or C1-6 alkyl, which in each case are unsubstituted or mono-, di-, or tri-substituted by halogen; unsubstituted or substituted C4-8 aliphatic heterocyclyl, comprising at least one nitrogen atom; unsubstituted or substituted aryl; unsubstituted or substituted heteroaryl; spiro [4.5] unsubstituted or substituted decane, which comprises one or two heteroatoms selected from oxygen, nitrogen, and sulfur; unsubstituted or substituted C3-6 cycloalkyl; or 1-aza-C5-8 cycloalkyl; b) unsubstituted or substituted N-C1-4-piperidinyl or N-cycloalkylC4-6-piperidinyl; c) substituted or substituted aryl; d) unsubstituted or substituted C3-6 cycloalkyl; or e) unsubstituted or substituted 5 or 6 membered heteroaryl containing a nitrogen atom; and R5 represents hydrogen or C1-4 alkyl; or R4 and R5, together with the nitrogen with which they are attached, represent unsubstituted or substituted C4-8 aliphatic heterocyclyl, comprising at least one nitrogen atom; or R2 denotes -N (R9) SO2R10; R9 represents hydrogen or C1-4 alkyl; and R10 represents C1-4 alkyl, which is unsubstituted or substituted by aryl; or R9 and R10 together form a radical - (CRR ') m-, where m is an integer from and including 2 and to and including 5, and R and R' both represent, independently of each other, hydrogen or C1- alkyl 4; R3 denotes hydrogen, halogen, phenyl, pyridyl, which is unsubstituted or mono-, di-, or tri-substituted by halogen, Y-R6, or NR7R8, wherein: Y represents O, CH2, S, SO, SO2, or NRN, wherein RN denotes hydrogen or C1-4 alkyl which is unsubstituted or substituted by C1-4 alkoxy; R6 represents C1-6 alkyl, phenyl, 5- or 6-membered nitrogen containing heteroyl- (CO2) q-, wherein q is an integer from 0 to 4, or 5 or 6 membered aliphatic heterocyclyl- (CH2) n- , wherein n is an integer from 0 to 4 and the heterocyclyl fraction comprises at least one ring nitrogen atom, whose radicals in each case may be unsubstituted or substituted; R7 and R8, together with the nitrogen to which they are attached, represent unsubstituted or substituted 5 or 6-membered aliphatic heterocyclyl, wherein the heterocyclyl fraction comprises at least one nitrogen atom; X denotes O, HN, C1-4-N alkyl, S, SO, SO2, O (CH2) gNH, where g is 1 or 2, (CH2) h, where h is 1 or 2, or aryl that is unsubstituted or mono-, di-, or tri-substituted by halogen, C1-4 alkyl, or C1-4 alkoxy; or a tautomer and / or salt of this 2-cyano-pyrimidine.
priorityDate 2004-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID266984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25774
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02765
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8HY81
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15600
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8HY82
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416170731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70370
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100153090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2757979
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 64.